Long-Acting Injectable HIV PrEP PROs
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- Anupama Raghuram MD
- Study ID
- NCT07379658
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- HIV Pre-exposure Prophylaxis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Interview and survey to evaluate patient reported outcomes between the two medications. — OTHERNo intervention, the two cohorts will receive the same surveys and interviews.
Study Details
The goal of this observational study is to learn about the real world effectiveness, patient satisfaction and clinical outcomes of LAI PrEP with lenacapavir (LEN) versus cabotegravir (CAB) through surveys and interviews. Participants receiving or initiating LAI PrEP part of their regular medical care will complete surveys and interviews at three study visits over the course of 12 months.
Key Dates
- Start date
- Jan 15, 2026
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 128 participants (estimated)
Arms
- Arm: LEN LAI PrEPThose receiving or initiating LEN LAI PrEP
- Arm: CAP LAI PrEPThose receiving or initiating CAB LAI PrEP
Primary Outcome Measure
LAI-SQ-6 Survey, Long-Acting Injectable Satisfaction Questionnaire [ Time Frame: Time of Enrollment, 6 months, 12 months ]
Central Contacts
- NIDI Research Clinic502-861-4646
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Norton Healthcare | Louisville | Kentucky | 40202 | NIDI Research Clinic |
| University of Louisville, Kent School of Social Work | Louisville | Kentucky | 40292 | Lesley Harris, MSW, PhD (SUB_INVESTIGATOR) |
| University of Louisville, School of Public Health and Information Sciences | Louisville | Kentucky | 40202 | Jelani Kerr, MSPH, PhD (SUB_INVESTIGATOR) |
Find similar trials in Louisville, KY
Related Studies
- Client-Centered Care Coordination for Black Men Who Have Sex With MenEnrolling By Invitation · University of Maryland, Baltimore · Washington D.C., District of Columbia
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)Not Yet Recruiting · University of Georgia · Colbert, Georgia
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Birmingham, Alabama
- Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)PHASE3 · Recruiting · Gilead Sciences · Birmingham, Alabama